I spent a delightful weekend in Hanover/Lebanon, New Hampshire at the invitation of Jack Wennberg, Dartmouth medical school pioneer in small area variations research – better explained to any audience, as Jack puts it, that “geography is destiny” in US health care. How you are treated may depend on where you live. It has become one of the most important themes of health policy discussion in the US today.
About 100 of Jack’s friends and colleagues gathered to tell stories about 40 years of this research path. There were linkages to his days at Johns Hopkins in the 60s, to Vermont in the early 70s, his attempt to get his early work published in that era (rejected by major medical journals), to his move to Dartmouth in 1979, and fast-forwarding to his impact on the national health care reform discussion today.
The celebration was an entertaining, educational and emotional evening.
That 40-year history is captured in Wennberg’s new book, “Tracking Medicine: A Researcher’s Quest To Understand Health Care.”
I had the honor of working right down the hallway from Wennberg throughout the 90s at Dartmouth Medical School. He was co-founder of the Foundation for Informed Medical Decision Making, for whom I produced shared decision-making programs. FIMDM is now the sole sponsor of my HealthNewsReview.org project.
From him I learned the unforgettable lesson to question conventional wisdom in health care. I’ve tried to share that every day with students and with professional journalists.
I will be forever indebted to him.
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like